Atossa shareholders approve reverse stock split up to 20:1, re-elect directors

ATOSSA THERAPEUTICS, INC.

Reverse stock split amendment approved: 2,336,815 for, 1,866,873 against, 33,271 abstentions.
Three Class II directors re-elected: Galli, Steinhart, Cigler; broker non-votes ~2.2M each.
Ratification of Ernst & Young as auditor for FY 2026 passed: 3.7M for, 370K against, 151K abstentions.
Advisory vote on executive compensation approved: 1.53M for, 444K against, 2.22M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.